Literature DB >> 2109156

Tumor necrosis factor alpha and interferon gamma inhibit proliferation and alkaline phosphatase activity of human osteoblastic SaOS-2 cell line.

R Yoshihara1, S Shiozawa, Y Imai, T Fujita.   

Abstract

Tumor necrosis factor (TNF) alpha and TNF beta both inhibited proliferation of cultured human osteoblastic SaOS-2 cells. TNF alpha also inhibited alkaline phosphatase (ALP) activity in the cells. The TNF alpha-induced inhibition of proliferation and ALP activity was further potentiated by interferon (IFN) gamma. These findings indicate that human SaOS-2 cells, fulfilling several criteria for osteoblasts, respond to TNF alpha and IFN gamma, resulting in decceleration of their maturation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109156

Source DB:  PubMed          Journal:  Lymphokine Res        ISSN: 0277-6766


  4 in total

Review 1.  Effects of anti-tumor necrosis factor α agents on bone.

Authors:  Vivian K Kawai; C Michael Stein; Daniel S Perrien; Marie R Griffin
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

Review 2.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

3.  Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD.

Authors:  Lishu Zhang; Yan-Fang Guo; Yao-Zhong Liu; Yong-Jun Liu; Dong-Hai Xiong; Xiao-Gang Liu; Liang Wang; Tie-Lin Yang; Shu-Feng Lei; Yan Guo; Han Yan; Yu-Fang Pei; Feng Zhang; Christopher J Papasian; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

4.  Integrative Analysis of Regulatory Module Reveals Associations of Microgravity with Dysfunctions of Multi-body Systems and Tumorigenesis.

Authors:  Mengqin Yuan; Haizhou Liu; Shunheng Zhou; Xu Zhou; Yu-E Huang; Fei Hou; Wei Jiang
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.